Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M. Sperger, Joshua M. Lang, Toni K. Choueiri et al.|Journal of Clinical Oncology|2021Cited by 62
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Jamie M. Sperger et al.|Journal of Clinical Investigation|2022Cited by 33
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M. Bade, Joshua M. Lang, Jennifer L. Schehr et al.|Molecular Oncology|2021Cited by 24
Centrosome amplification is a frequent event in circulating tumor cells from subjects with metastatic breast cancerAshok Singh, Joshua M. Lang, Ryan A. Denu et al.|Molecular Oncology|2020Cited by 22